Schedule 13D ownership disclosure
AEON Biopharma, Inc.
Class A Common Stock · CUSIP: 00791X100
Event date: 2024-07-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Robert J PalmisanoReported CIK 0001138646
Shares: 2,265,000.00 · Class: 5.7%
- The Palmisano Family, LLC
Shares: 2,265,000.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-005235
- Form type
- SCHEDULE 13D
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Jan 22, 2025
- Reporting period
- Jul 25, 2024
- Description
- Schedule 13D beneficial ownership